Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.60 |
| ▸ | DRD4 | P21917 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 4/20 | 0.53 |
| ▸ | HTR2A | P28223 | 4/20 | 0.53 |
| ▸ | DRD3 | P35462 | 3/20 | 0.53 |
| ▸ | DRD1 | P21728 | 2/20 | 0.53 |
| ▸ | DRD5 | P21918 | 2/20 | 0.53 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 2/20 | 0.49 |
| ▸ | HTR7 | P34969 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107784 | 0.90 | KDM4E (0.62) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL106864 | 0.86 | KCNH2 (0.71) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL15471059 | 0.84 | KCNH2 (0.68) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL8011318 | 0.83 | DRD2 (0.69) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL13875126 | 0.82 | KDM4E (0.69) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL8223307 | 0.81 | KDM4E (0.62) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL13140417 | 0.80 | DRD2 (0.59) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL23339990 | 0.78 | DRD2 (0.55) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL2090615 | 0.78 | DRD2 (0.59) | DRD2DRD4HTR1AHTR2ADRD3 | |
| SCHEMBL5915112 | 0.77 | DRD2 (0.68) | DRD2HTR1AHTR2ADRD3DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120129100-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120129100-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME | ACTR8, RAD51, ACTR2 | DRD2 1429/4885DRD4 2711/4885HTR1A 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.